Seroatlas · Human Serome Atlas

MPZL2

Myelin protein zero-like protein 2

Also known as: EVA, EVA1, MPZL2_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O60487
Gene
MPZL2
Ensembl
ENSG00000149573
Chromosome
11
Canonical length
215 aa
Protein class
Disease related genes, Human disease related genes, Predicted membrane proteins
Subcellular location
Cell Junctions

OverviewNCBI Gene

Thymus development depends on a complex series of interactions between thymocytes and the stromal component of the organ. Epithelial V-like antigen (EVA) is expressed in thymus epithelium and strongly downregulated by thymocyte developmental progression. This gene is expressed in the thymus and in several epithelial structures early in embryogenesis. It is highly homologous to the myelin protein zero and, in thymus-derived epithelial cell lines, is poorly soluble in nonionic detergents, strongly suggesting an association to the cytoskeleton. Its capacity to mediate cell adhesion through a homophilic interaction and its selective regulation by T cell maturation might imply the participation of EVA in the earliest phases of thymus organogenesis. The protein bears a characteristic V-type domain and two potential N-glycosylation sites in the extracellular domain; a putative serine phosphorylation site for casein kinase 2 is also present in the cytoplasmic tail. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

215 residues, UniProt reviewed canonical sequence.

>O60487|MPZL2
     1  MYGKSSTRAV LLLLGIQLTA LWPIAAVEIY TSRVLEAVNG TDARLKCTFS SFAPVGDALT
    61  VTWNFRPLDG GPEQFVFYYH IDPFQPMSGR FKDRVSWDGN PERYDASILL WKLQFDDNGT
   121  YTCQVKNPPD VDGVIGEIRL SVVHTVRFSE IHFLALAIGS ACALMIIIVI VVVLFQHYRK
   181  KRWAERAHKV VEIKSKEEER LNQEKKVSVY LEDTD

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against MPZL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.39
Highest tissue expression
208 nTPM

Expression across tissuesHPA

Tissue

  • esophagus: 208 nTPM
  • urinary bladder: 146 nTPM
  • vagina: 118 nTPM
  • cervix: 86 nTPM
  • seminal vesicle: 66 nTPM
  • salivary gland: 53 nTPM

Single-cell type

  • esophageal apical cells: 1,438 nCPM
  • esophageal suprabasal cells: 943 nCPM
  • suprabasal keratinocytes: 532 nCPM
  • ocular epithelial cells: 418 nCPM
  • esophageal basal cells: 351 nCPM
  • basal keratinocytes: 313 nCPM

Immune cell

  • myeloid DC: 17 nTPM
  • neutrophil: 13 nTPM
  • classical monocyte: 12 nTPM
  • intermediate monocyte: 9.2 nTPM
  • total PBMC: 3.8 nTPM
  • eosinophil: 3 nTPM

Brain region

  • choroid plexus: 7.5 nTPM
  • spinal cord: 4.2 nTPM
  • thalamus: 4.1 nTPM
  • medulla oblongata: 3.4 nTPM
  • pons: 3.3 nTPM
  • white matter: 2.5 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about MPZL2.

Disease | AllUniProt

Conditions MPZL2 is implicated in, by any mechanism.

Disease | GeneticClinVar

18 pathogenic / likely-pathogenic of 76 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.86
gnomAD pLI
0
gnomAD missense Z
-0.48
DepMap mean gene effect
-0.04
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads MPZL2 as an antibody target. Whether an autoantibody or antibody against MPZL2 could matter depends on whether native MPZL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

MPZL2 is annotated at the cell surface, where native MPZL2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label MPZL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/MPZL2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...